Who Owns ProKidney Stock?
NASDAQ: PROKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 29.81%
- Held by insiders
- 46.52%
- Institutional holders
- 123
- Institutions 29.8%
- Insiders 46.5%
- Public and other 23.7%
Who owns ProKidney stock?
Institutional investors own about 29.8% of ProKidney's shares, spread across 123 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 46.52% of PROK.
The largest institutional holders are Montanova Capital LLC (5.91%), Morgan Stanley (4.71%) and Blackrock Inc. (3.81%). Together, the top 10 institutions control 21.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PROK positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PROK
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Montanova Capital LLC | 12.34M | 5.91% | 0.0% |
| Morgan Stanley | 9.85M | 4.71% | -0.0% |
| Blackrock Inc. | 7.97M | 3.81% | +53.4% |
| Geode Capital Management, LLC | 3.59M | 1.72% | +50.2% |
| Propel Bio Management, LLC | 2.01M | 0.96% | +100.0% |
| Bleichroeder LP | 1.90M | 0.91% | -5.0% |
| State Street Corporation | 1.81M | 0.87% | +73.1% |
| Artia Global Partners LP | 1.81M | 0.86% | 0.0% |
| Hennion & Walsh Asset Management, Inc. | 1.81M | 0.86% | -2.2% |
| Vanguard Capital Management LLC | 1.73M | 0.83% | +46.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PROK
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 2.67M | 1.28% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.18M | 0.56% |
| Morgan Stanley Insight Fund | 1.12M | 0.54% |
| Brighthouse Funds Trust I-Morgan Stanley Discovery Portfolio | 1.08M | 0.52% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 822.12K | 0.39% |
| MORGAN STANLEY INSTITUTIONAL FUND TRUST-Discovery Portfolio | 820.88K | 0.39% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 761.58K | 0.36% |
| iShares Trust-iShares Russell 2000 Growth ETF | 687.64K | 0.33% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 500.39K | 0.24% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 437.36K | 0.21% |
Frequently asked questions
Who is the largest shareholder of ProKidney?
Montanova Capital LLC is the largest institutional shareholder of PROK, owning 5.91% of shares outstanding (12.34M shares) as of its latest 13F filing.
What percentage of ProKidney is owned by institutions?
Institutions own about 29.8% of PROK shares and 55.7% of the public float.
How much of ProKidney do insiders own?
Insiders, such as officers and directors, own about 46.52% of PROK shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.